These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37227224)

  • 1. Renal injury in relation to obesity and the additive effect of hypertension in female and male obese and lean ZSF1 rats.
    Nguyen ITN; Cramer MJ; Joles JA; Verhaar MC
    Am J Physiol Renal Physiol; 2023 Jul; 325(1):F73-F86. PubMed ID: 37227224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
    Nguyen ITN; Brandt MM; van de Wouw J; van Drie RWA; Wesseling M; Cramer MJ; de Jager SCA; Merkus D; Duncker DJ; Cheng C; Joles JA; Verhaar MC
    PLoS One; 2020; 15(5):e0232399. PubMed ID: 32374790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Captopril Attenuates Cardiovascular and Renal Disease in a Rat Model of Heart Failure With Preserved Ejection Fraction.
    Salah EM; Bastacky SI; Jackson EK; Tofovic SP
    J Cardiovasc Pharmacol; 2018 Apr; 71(4):205-214. PubMed ID: 29620605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct Endothelial Cell Responses in the Heart and Kidney Microvasculature Characterize the Progression of Heart Failure With Preserved Ejection Fraction in the Obese ZSF1 Rat With Cardiorenal Metabolic Syndrome.
    van Dijk CG; Oosterhuis NR; Xu YJ; Brandt M; Paulus WJ; van Heerebeek L; Duncker DJ; Verhaar MC; Fontoura D; Lourenço AP; Leite-Moreira AF; Falcão-Pires I; Joles JA; Cheng C
    Circ Heart Fail; 2016 Apr; 9(4):e002760. PubMed ID: 27056881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model.
    Hamdani N; Franssen C; Lourenço A; Falcão-Pires I; Fontoura D; Leite S; Plettig L; López B; Ottenheijm CA; Becher PM; González A; Tschöpe C; Díez J; Linke WA; Leite-Moreira AF; Paulus WJ
    Circ Heart Fail; 2013 Nov; 6(6):1239-49. PubMed ID: 24014826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute and chronic effects of levosimendan in the ZSF1 obese rat model of heart failure with preserved ejection fraction.
    Moreira-Costa L; Tavares-Silva M; Almeida-Coelho J; Gonçalves A; Trindade F; Vasques-Nóvoa F; Sousa-Mendes C; Leite S; Vitorino R; Falcão-Pires I; Leite-Moreira AF; Lourenço AP
    Eur J Pharmacol; 2024 Mar; 966():176336. PubMed ID: 38272343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial Remodeling and Dysfunction in the ZSF1 Rat Model of Heart Failure With Preserved Ejection Fraction.
    Leite S; Cerqueira RJ; Ibarrola J; Fontoura D; Fernández-Celis A; Zannad F; Falcão-Pires I; Paulus WJ; Leite-Moreira AF; Rossignol P; López-Andrés N; Lourenço AP
    Circ Heart Fail; 2019 Jul; 12(7):e005596. PubMed ID: 31525070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Limited synergy of obesity and hypertension, prevalent risk factors in onset and progression of heart failure with preserved ejection fraction.
    Brandt MM; Nguyen ITN; Krebber MM; van de Wouw J; Mokry M; Cramer MJ; Duncker DJ; Verhaar MC; Joles JA; Cheng C
    J Cell Mol Med; 2019 Oct; 23(10):6666-6678. PubMed ID: 31368189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction.
    Oliveira MI; Leite S; Barros A; Lourenço AP; Mendes C; Schmidt C; Santos M; Leite-Moreira A; Moreira-Gonçalves D
    Exp Physiol; 2021 Dec; 106(12):2457-2471. PubMed ID: 34676608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between the gut microbiome, associated metabolites and the manifestation and progression of heart failure with preserved ejection fraction in ZSF1 rats.
    Guivala SJ; Bode KA; Okun JG; Kartal E; Schwedhelm E; Pohl LV; Werner S; Erbs S; Thiele H; Büttner P
    Cardiovasc Diabetol; 2024 Aug; 23(1):299. PubMed ID: 39143579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A directed network analysis of the cardiome identifies molecular pathways contributing to the development of HFpEF.
    Summer G; Kuhn AR; Munts C; Miranda-Silva D; Leite-Moreira AF; Lourenço AP; Heymans S; Falcão-Pires I; van Bilsen M
    J Mol Cell Cardiol; 2020 Jul; 144():66-75. PubMed ID: 32422321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A G-protein-biased S1P1 agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome.
    Evaristi MF; Poirier B; Chénedé X; Lefebvre AM; Roccon A; Gillot F; Beeské S; Corbier A; Pruniaux-Harnist MP; Janiak P; Parkar AA
    PLoS One; 2022; 17(1):e0257929. PubMed ID: 35030174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic blood pressure load and nephropathy in the ZSF1 (fa/fa cp) model of type 2 diabetes.
    Griffin KA; Abu-Naser M; Abu-Amarah I; Picken M; Williamson GA; Bidani AK
    Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1605-13. PubMed ID: 17728379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Sildenafil Therapy in the ZSF1 Obese Rat Model of Metabolic Syndrome and Heart Failure With Preserved Ejection Fraction.
    Leite S; Moreira-Costa L; Cerqueira R; Sousa-Mendes C; Angélico-Gonçalves A; Fontoura D; Vasques-Nóvoa F; Leite-Moreira AF; Lourenço AP
    J Cardiovasc Pharmacol Ther; 2021 Nov; 26(6):690-701. PubMed ID: 34328815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disturbed cardiac mitochondrial and cytosolic calcium handling in a metabolic risk-related rat model of heart failure with preserved ejection fraction.
    Miranda-Silva D; Wüst RCI; Conceição G; Gonçalves-Rodrigues P; Gonçalves N; Gonçalves A; Kuster DWD; Leite-Moreira AF; van der Velden J; de Sousa Beleza JM; Magalhães J; Stienen GJM; Falcão-Pires I
    Acta Physiol (Oxf); 2020 Mar; 228(3):e13378. PubMed ID: 31520455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
    Stolina M; Luo X; Dwyer D; Han CY; Chen R; Zhang Y; Xiong Y; Chen Y; Yin J; Shkumatov A; Ason B; Hale C; Véniant MM
    PLoS One; 2020; 15(8):e0231234. PubMed ID: 32804947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetylation and phosphorylation changes to cardiac proteins in experimental HFpEF due to metabolic risk reveal targets for treatment.
    Koser F; Hobbach AJ; Abdellatif M; Herbst V; Türk C; Reinecke H; Krüger M; Sedej S; Linke WA
    Life Sci; 2022 Nov; 309():120998. PubMed ID: 36179815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of homoarginine supplementation on heart and skeletal muscle of rats with heart failure with preserved ejection fraction.
    Büttner P; Adams V; Werner S; Ossmann S; Besler C; Schwedhelm E; Thiele H
    ESC Heart Fail; 2022 Dec; 9(6):4348-4351. PubMed ID: 36043453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Training Reveals Inflexibility of the Diaphragm in an Animal Model of Patients With Obesity-Driven Heart Failure With a Preserved Ejection Fraction.
    Bowen TS; Brauer D; Rolim NPL; Bækkerud FH; Kricke A; Ormbostad Berre AM; Fischer T; Linke A; da Silva GJ; Wisloff U; Adams V
    J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29066440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Afterload-induced diastolic dysfunction contributes to high filling pressures in experimental heart failure with preserved ejection fraction.
    Leite S; Rodrigues S; Tavares-Silva M; Oliveira-Pinto J; Alaa M; Abdellatif M; Fontoura D; Falcão-Pires I; Gillebert TC; Leite-Moreira AF; Lourenço AP
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(10):H1648-54. PubMed ID: 26408538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.